Oral glutamine challenge predicts and identifies long-term ammonia-related overt hepatic encephalopathy

被引：0
|
作者：
Ampuero, Javier [1 ,2 ]
Gil-Gomez, Antonio [2 ]
del Mar Viloria, Maria [3 ]
Montoliu, Carmina [4 ]
Simon-Talero, Macarena [6 ]
del Carmen Rico, Maria [2 ]
Camacho, Ines M. [3 ]
Angel Serra, Miguel [5 ]
Vilar-Gomez, Eduardo [1 ,2 ]
Romero-Gomez, Manuel [1 ,2 ]
机构：
[1] Virgen del Rocio Virgen Macarena Univ Hosp, Interctr Unit Digest Dis, Seville, Spain
[2] Inst Biomed Sevilla, Ciberehd, Seville, Spain
[3] Valme Univ Hosp, Seville, Spain
[4] Inst Invest Sanitaria INCLIVA, Valencia, Spain
[5] Clin Univ Hosp, Valencia, Spain
[6] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1425
引用
收藏
页码：713A / 713A
页数：1
相关论文
共 50 条
  • [21] The Long Term Efficacy and Safety of Rifaximin in the Maintenance of Remission From Overt Hepatic Encephalopathy in Cirrhotic Patients
    Mullen, Kevin D.
    Sanyal, Arun J.
    Bass, Nathan M.
    Poordad, Fred
    Huang, Shirley
    Merchant, Kunal
    Bortey, Enoch
    Forbes, William P.
    GASTROENTEROLOGY, 2012, 142 (05) : S41 - S42
  • [22] Oral Glutamine Challenge Improves the Performance of Psychometric Tests for the Diagnosis of Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis
    Irimia, Roxana
    Stanciu, Carol
    Cojocariu, Camelia
    Sfarti, Catalin
    Trifan, Anca
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2013, 22 (03) : 277 - 281
  • [23] LONG TERM CARE SERVICES USE AMONG MEDICARE PATIENTS TREATED WITH RIFAXIMIN FOR OVERT HEPATIC ENCEPHALOPATHY
    Gagnon-Sanschagrin, Patrick
    Heimanson, Zeev
    Allen, Christopher
    Maitland, Jessica
    Davidson, Mikhail
    Zhang, Adina
    Chen, Jingyi
    Guerin, Annie
    Dashputre, Ankur A.
    Bumpass, Brock
    Olujohungbe, Olamide
    Borroto, Danellys
    Joseph, George
    GASTROENTEROLOGY, 2023, 164 (06) : S1400 - S1400
  • [24] Hepatic steatosis predicts fibrosis in long-term methotrexate use
    Tomaszewski, Marcel
    Dahiya, Monica
    Mohajerani, Amir
    Ko, Hin Hin
    Punja, Hanaa
    Ramji, Alnoor
    JOURNAL OF HEPATOLOGY, 2020, 73 : S232 - S232
  • [25] Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
    Hudson, Mark
    Schuchmann, Marcus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) : 434 - 450
  • [26] LONG-TERM OUTCOMES FOR LIVER TRANSPLANT RECIPIENTS IN TERMS OF HEPATIC ENCEPHALOPATHY
    You, Dongdo
    Choi, Gyuseong
    Kim, Jong Man
    Kwon, Choon Hyuck
    Joh, Jae-Won
    Lee, Suk-Koo
    TRANSPLANT INTERNATIONAL, 2017, 30 : 278 - 278
  • [27] Long-term Outcomes for Liver Transplant Recipients in Terms of Hepatic Encephalopathy
    You, D. D.
    Choi, G. S.
    Kim, J. M.
    Kwon, C. H. D.
    Joh, J. -W.
    Lee, S. -K.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (06) : 1425 - 1429
  • [28] Pattern of Brain Injury Predicts Long-Term Epilepsy Following Neonatal Encephalopathy
    Xu, Qi
    Chau, Vann
    Sanguansermsri, Chinnuwat
    Muir, Katherine E.
    Tam, Emily W. Y.
    Miller, Steven P.
    Wong, Darren S. T.
    Chen, Hao
    Wong, Peter K. H.
    Zwicker, Jill G.
    Poskitt, Kenneth J.
    Hill, Alan
    Roland, Elke H.
    JOURNAL OF CHILD NEUROLOGY, 2019, 34 (04) : 199 - 209
  • [29] Long-term octreotide therapy does not predispose to the development of hepatic encephalopathy.
    Khan, S
    Roberts, N
    Robinson, A
    Sutton, R
    Baxter, JN
    Jenkins, SA
    GUT, 1999, 44 : A57 - A57
  • [30] COMPARISON OF RESULTS OF LONG-TERM TREATMENT OF CHRONIC HEPATIC ENCEPHALOPATHY WITH LACTULOSE AND SORBITOL
    RODGERS, JB
    KILEY, JE
    BALINT, JA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1973, 60 (05): : 459 - 465
12345